-Michael Bouvet Researcher Activity Profile

Research Author Detailed Information 

Michael Bouvet Publication Rate By Year

Michael Bouvet has published 1 paper(s) in 2003, 1 paper(s) in 2004, 2 paper(s) in 2006, 10 paper(s) in 2007, 3 paper(s) in 2008, for a total of 17 research publications in total.

Michael M Bouvet Author Information

LAST NAME: bouvet

FIRST NAME: michael

INITIALS: M

AFFILIATION:

Papers

Michael Bouvet's Publication Record

1. Selective antimetastatic activity of cytosine analog CS-682 in a red fluorescent protein orthotopic model of pancreatic cancer. Year Published: 2003
Department of Surgery, University of California at San Diego, San Diego, California 92161, USA.
2. Survival efficacy of adjuvant cytosine-analogue CS-682 in a fluorescent orthotopic model of human pancreatic cancer. Year Published: 2004
Department of Surgery, University of California at San Diego, San Diego, California, USA.
3. Dual-color imaging of nascent angiogenesis and its inhibition in liver metastases of pancreatic cancer. Year Published: 2006
AntiCancer, Inc., 7917 Ostrow Street, San Diego, California, USA.
4. In vivo color-coded imaging of the interaction of colon cancer cells and splenocytes in the formation of liver metastases. Year Published: 2006
Department of Surgery, University of California, San Diego, USA.
5. Visualization of nascent tumor angiogenesis in lung and liver metastasis by differential dual-color fluorescence imaging in nestin-linked-GFP mice. Year Published: 2007
AntiCancer, Inc., 7917 Ostrow Street, San Diego, CA 92111, USA.
6. Determination of the ligand-binding specificities of the alpha2beta1 and alpha1beta1 integrins in a novel 3-dimensional in vitro model of pancreatic cancer. Year Published: 2007
Department of Surgery, University of California San Diego, San Diego, CA, USA.
7. GFP-expressing vascularization of Gelfoam as a rapid in vivo assay of angiogenesis stimulators and inhibitors. Year Published: 2007
AntiCancer, Inc., San Diego, CA 92111, USA.
8. Dual-color imaging of angiogenesis and its inhibition in bone and soft tissue sarcoma. Year Published: 2007
Department of Surgery, University of California San Diego, San Diego, California, USA.
9. Real-time imaging of tumor-cell shedding and trafficking in lymphatic channels. Year Published: 2007
AntiCancer Inc, San Diego, CA 92111-3604, USA.
10. Imaging of nucleolar dynamics during the cell cycle of cancer cells in live mice. Year Published: 2007
AntiCancer, Inc., San Diego, California 92111-3604, USA.
11. Imaging of nucleolar dynamics during the cell cycle of cancer cells in live mice. Year Published: 2007
AntiCancer, Inc., San Diego, California 92111-3604, USA.
12. The integrin-extracellular matrix axis in pancreatic cancer. Year Published: 2007
Department of Surgery, University of California, San Diego, CA, USA.
13. The integrin-extracellular matrix axis in pancreatic cancer. Year Published: 2007
Department of Surgery, University of California, San Diego, CA, USA.
14. Induction of cancer metastasis by cyclophosphamide pretreatment of host mice: an opposite effect of chemotherapy. Year Published: 2008
AntiCancer, Inc., San Diego, CA 92111, USA.
15. The integrin-extracellular matrix axis in pancreatic cancer. Year Published: 2007
Department of Surgery, University of California, San Diego, CA, USA.
16. Induction of cancer metastasis by cyclophosphamide pretreatment of host mice: an opposite effect of chemotherapy. Year Published: 2008
AntiCancer, Inc., San Diego, CA 92111, USA.
17. Activation of the alpha2beta1 integrin-mediated malignant phenotype on type I collagen in pancreatic cancer cells by shifts in the concentrations of extracellular Mg2+ and Ca2+. Year Published: 2008
Department of Surgery, VA San Diego Healthcare System and the University of California, San Diego, CA, USA.